A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder

Khan, Arifulla; Joyce, Mark; Atkinson, Sarah; Eggens, Ivan; Baldytcheva, Irina; Eriksson, Hans

doi:10.1097/jcp.0b013e318224864d

Public

A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder

Published in Journal of Clinical Psychopharmacology • Jun 21, 2011

Authors:

Arifulla Khan

Mark Joyce

Sarah Atkinson

Abstract

This study evaluated once-daily, extended-release quetiapine fumarate (quetiapine XR) monotherapy in generalized anxiety disorder (GAD). This was a 10-week (8-week active treatment/2-week posttreatment drug-discontinuation/tapering phase), double-blind, randomized, placebo-controlled study (D1448C00...

Subject

Quetiapine

Quetiapine Fumarate

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!